Interleukin-6 and procalcitonin in children with sepsis and septic shock. 2008

José R Fioretto, and Joelma G Martin, and Cilmery S Kurokawa, and Mário F Carpi, and Rossano C Bonatto, and Sandra M Q Ricchetti, and Marcos A de Moraes, and Carlos R Padovani
Pediatric Intensive Care Unit, Pediatrics Department, Botucatu Medical School, Sao Paulo State University-UNESP, Sao Paulo, Brazil. jrf@fmb.unesp.br

OBJECTIVE To examine the behavior of interleukin-6 (IL-6) and procalcitonin (PCT) and verify whether they can be used to differentiate children with septic conditions. METHODS Septic children aged between 28 days and 14 years, prospectively enrolled from 01/2004 to 12/2005, were divided into sepsis (SG; n=47) and septic shock (SSG; n=43) groups. IL-6 and PCT were measured at admission (T0) and 12h later (T12h). PCT results were classed as: 0.5 ng/mL=sepsis unlikely; > or =0.5 to <2=sepsis possible; > or =2 to <10=systemic inflammation; > or =10=septic shock. RESULTS Ninety children were included. At T0, there was a higher frequency of SSG with higher PCT compared with SG [SSG: 30 (69.7%)>SG: 14 (29.8%); p<0.05]. Similar results were observed at T12h. PRISM was significantly higher for SSG patients with higher PCT than SG patients. At T0, IL-6 levels were higher in SSG [SSG: 213.10 (10.85-396.70)>SG: 63.21 (0.86-409.82); p=0.001], but not statistically different at T12h. IL-6 levels positively correlated with PRISM score in SSG patients at admission (p=0.001; r=0.86). CONCLUSIONS PCT and IL-6 appear to be helpful in early assessment of pediatric sepsis, are of diagnostic value at admission, and are related to disease severity.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D011498 Protein Precursors Precursors, Protein
D002116 Calcitonin A peptide hormone that lowers calcium concentration in the blood. In humans, it is released by thyroid cells and acts to decrease the formation and absorptive activity of osteoclasts. Its role in regulating plasma calcium is much greater in children and in certain diseases than in normal adults. Thyrocalcitonin,Calcitonin(1-32),Calcitrin,Ciba 47175-BA,Eel Calcitonin,Calcitonin, Eel,Ciba 47175 BA,Ciba 47175BA
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

José R Fioretto, and Joelma G Martin, and Cilmery S Kurokawa, and Mário F Carpi, and Rossano C Bonatto, and Sandra M Q Ricchetti, and Marcos A de Moraes, and Carlos R Padovani
March 2015, Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals,
José R Fioretto, and Joelma G Martin, and Cilmery S Kurokawa, and Mário F Carpi, and Rossano C Bonatto, and Sandra M Q Ricchetti, and Marcos A de Moraes, and Carlos R Padovani
March 2024, Nigerian journal of clinical practice,
José R Fioretto, and Joelma G Martin, and Cilmery S Kurokawa, and Mário F Carpi, and Rossano C Bonatto, and Sandra M Q Ricchetti, and Marcos A de Moraes, and Carlos R Padovani
September 1996, Critical care medicine,
José R Fioretto, and Joelma G Martin, and Cilmery S Kurokawa, and Mário F Carpi, and Rossano C Bonatto, and Sandra M Q Ricchetti, and Marcos A de Moraes, and Carlos R Padovani
January 2017, PloS one,
José R Fioretto, and Joelma G Martin, and Cilmery S Kurokawa, and Mário F Carpi, and Rossano C Bonatto, and Sandra M Q Ricchetti, and Marcos A de Moraes, and Carlos R Padovani
May 2014, Critical care (London, England),
José R Fioretto, and Joelma G Martin, and Cilmery S Kurokawa, and Mário F Carpi, and Rossano C Bonatto, and Sandra M Q Ricchetti, and Marcos A de Moraes, and Carlos R Padovani
January 2002, Terapevticheskii arkhiv,
José R Fioretto, and Joelma G Martin, and Cilmery S Kurokawa, and Mário F Carpi, and Rossano C Bonatto, and Sandra M Q Ricchetti, and Marcos A de Moraes, and Carlos R Padovani
March 2013, Medicina intensiva,
José R Fioretto, and Joelma G Martin, and Cilmery S Kurokawa, and Mário F Carpi, and Rossano C Bonatto, and Sandra M Q Ricchetti, and Marcos A de Moraes, and Carlos R Padovani
August 2021, Interventional medicine & applied science,
José R Fioretto, and Joelma G Martin, and Cilmery S Kurokawa, and Mário F Carpi, and Rossano C Bonatto, and Sandra M Q Ricchetti, and Marcos A de Moraes, and Carlos R Padovani
May 2014, Critical care (London, England),
José R Fioretto, and Joelma G Martin, and Cilmery S Kurokawa, and Mário F Carpi, and Rossano C Bonatto, and Sandra M Q Ricchetti, and Marcos A de Moraes, and Carlos R Padovani
June 1992, [Rinsho ketsueki] The Japanese journal of clinical hematology,
Copied contents to your clipboard!